» Articles » PMID: 35085523

Aortic Arch Management During Acute and Subacute Type A Aortic Syndromes

Overview
Journal Ann Thorac Surg
Publisher Elsevier
Date 2022 Jan 27
PMID 35085523
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The purpose of this study was to compare the outcomes of no arch intervention, hemiarch replacement, and total arch replacement during type A aortic syndromes in a contemporary series.

Methods: From 2004 to 2019, 634 patients have required acute type A dissection repair; these patients were divided into three groups based on type of arch intervention performed: no arch (n = 130), hemiarch (n = 397), and total arch (n = 107). The primary endpoint was mortality; a multivariable risk factor analysis was performed. Secondary endpoints were reoperation and early and late complications.

Results: Operative age was 55 ± 14 years for the cohort and was similar between groups (P = .34). The incidence of peripheral artery disease, heart failure, and prior coronary artery bypass graft surgery differed between the groups (P < .05). Median cardiopulmonary bypass time, aortic cross-clamp time, and length of stay were longest for the total arch group (P < .0001). Early mortality was 20%, 10%, and 10% for the no-arch, hemiarch, and total arch groups, respectively (P = .01). Ten-year survival was 54%, 66%, and 65% for the no-arch, hemiarch, and total arch groups, respectively (P = .01). There was no difference in incidence or timing of redo aortic interventions (P > .05). For the entire cohort, risk factors for late mortality included preoperative peripheral artery disease (hazard ratio 2.3; 95% confidence interval, 1.2 to 4.4; P = .009) and preoperative dialysis (hazard ratio 2.8; 95% confidence interval, 1.3 to 6.1; P = .01).

Conclusions: Despite longer cardiopulmonary bypass and aortic cross-clamp times, arch intervention was not associated with worse operative or long-term outcome in this series. Patients with peripheral vascular disease and preoperative renal failure remain at highest risk for mortality after type A aortic dissection repair.

Citing Articles

Total Arch Replacement is Safe as Hemiarch Repair in Acute Type A Aortic Dissection in a Middle-Income Country Setting.

Nino-Calvera J, Senosiain J, Nunez-Ordonez N, Pineda I, Ramirez L, Villa C Braz J Cardiovasc Surg. 2025; 40(1):e20240088.

PMID: 39937874 PMC: 11817151. DOI: 10.21470/1678-9741-2024-0088.


Prognostic analysis of acute type A aortic dissection after different surgical interventions: a cohort study.

Zhu Q, Lv X, Li S, Li X, Zhang W, Xue J J Thorac Dis. 2025; 16(12):8709-8723.

PMID: 39831215 PMC: 11740025. DOI: 10.21037/jtd-2024-2048.


Outcomes of hemi- vs. total arch replacement in acute type A aortic dissection: A systematic review and meta-analysis.

Ma L, Chai T, Yang X, Zhuang X, Wu Q, Chen L Front Cardiovasc Med. 2022; 9:988619.

PMID: 36237909 PMC: 9552831. DOI: 10.3389/fcvm.2022.988619.


Th1, Th2, and Th17 cells are dysregulated, but only Th17 cells relate to C-reactive protein, D-dimer, and mortality risk in Stanford type A aortic dissection patients.

Song M, Deng L, Shen H, Zhang G, Shi H, Zhu E J Clin Lab Anal. 2022; 36(6):e24469.

PMID: 35522124 PMC: 9169215. DOI: 10.1002/jcla.24469.